In this blog piece #ChetanShah and #AnastaciaTew highlight that as the use of glucagon-like peptide-1 receptor agonists increases, so must our awareness of patients who have an eating disorder or who are at risk of developing one
#ukpharmacy #eatingdisorder #weightlossinjections
#ukpharmacy #eatingdisorder #weightlossinjections
The dark side of the ‘miracle jab’: why eating disorder safety cannot be an afterthought
In recent years, glucagon-like peptide-1 receptor agonists (GLP-1s), such as Ozempic (semaglutide; Novo Nordisk), Wegovy (semaglutide; Novo Nordisk) and Mounjaro (tirzepatide; Eli Lilly) have been…
buff.ly
February 10, 2026 at 8:30 AM
In this blog piece #ChetanShah and #AnastaciaTew highlight that as the use of glucagon-like peptide-1 receptor agonists increases, so must our awareness of patients who have an eating disorder or who are at risk of developing one
#ukpharmacy #eatingdisorder #weightlossinjections
#ukpharmacy #eatingdisorder #weightlossinjections